Phenylephrine Hydrochloride
- Product NDC
- 72603-520
- Requested package NDC
- 72603-520-02
- 11-digit product format
- 726030520
- Labeler code
- 72603
- Product ID
- 72603-520_e31ea9e0-264f-451a-84f7-578d3445e2dd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Phenylephrine Hydrochloride
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- NorthStar RxLLC
- Application
- ANDA216859
- Marketing category
- ANDA
- Marketing start
- 2024-10-01
- Substance
- PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 25 mg/mL
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A216859-001 | AT |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | 2022-09-29 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | 2022-09-29 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | 2022-09-29 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | 2022-09-29 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | 2022-09-29 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | 2022-09-29 | f41ea6bd6efb… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216859-001 | PHENYLEPHRINE HYDROCHLORIDE | 2.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RS | 2022-09-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216859-001 | AT | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A216859-001 | AT | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A216859-001 | AT | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216859-001 | AT | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A216859-001 | AT | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216859-001 | AT | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216859-001 | AT | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216859-001 | AT | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216859-001 | AT | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216859-001 | AT | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216859-001 | AT | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A216859-001 | AT | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216859-001 | AT | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216859-001 | AT | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216859-001 | AT | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A216859-001 | AT | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216859-001 | AT | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A216859-001 | AT | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A216859-001 | AT | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216859-001 | AT | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216859-001 | AT | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216859-001 | AT | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216859-001 | AT | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A216859-001 | AT | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A216859-001 | AT | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216859-001 | AT | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A216859-001 | AT | 1 | f41ea6bd6efb… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216859-001 | AT | 1 | a50c72e98297… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-12-20 04:57 UTC | 2023-12 | A216859-001 | CGT | 2023-04-05 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216859-001 | CGT | 2023-04-05 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216859-001 | CGT | 2023-04-05 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216859-001 | CGT | 2023-04-05 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216859-001 | CGT | 2023-04-05 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A216859-001 | CGT | 2023-04-05 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A216859-001 | CGT | 2023-04-05 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216859-001 | CGT | 2023-04-05 | 3a93d1ddd44b… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Phenylephrine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PHENYLEPHRINE HYDROCHLORIDE | 25 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 04JA59TNSJ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1234579 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3ce681eb-8580-49bf-962a-68a576fddd57 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e4e263da-1c53-440f-bb80-b7a575843b5a | Product name | 1 | 20260313 |
| d2168cac-a261-415a-9c78-3522859fa720 | Product name | 3 | 20251124 |
| 726062af-1135-4707-a1d7-57256991bbf9 | Product name | 2 | 20250226 |
| 05a8cdd1-eeb8-409e-b938-0778225eca7d | Product name | 4 | 20250221 |
| e5b5c132-b15d-435b-9faa-2f74e5cadcf9 | Product name | 8 | 20250220 |
| f489e8f3-5c9e-4818-b539-a73587edcfc7 | Product name | 2 | 20240229 |
| 0f7ae452-206d-4fc4-868d-56fc47074084 | Product name | 1 | 20231011 |
| b5abe2e3-39a1-43eb-9bff-f3c1653fe3df | Product name | 2 | 20190930 |
| e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814 | Product name | 3 | 20150910 |
| 19c71a3d-ed9c-166b-a7e5-38c250c35631 | Product name | 1 | 20140508 |
| 42f3c020-f1b3-89bc-7bdc-e1f10e680485 | Product name | 1 | 20140508 |
| e949165d-714d-e548-2b76-0cb5def16f30 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72603-520-01 | Phenylephrine Hydrochloride | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 1 | |
| 72603-520-01 | Phenylephrine Hydrochloride | 2 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 2 | 1 | |
| 72603-520-02 | Phenylephrine Hydrochloride | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 1 | |
| 72603-520-02 | Phenylephrine Hydrochloride | 15 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 15 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72603-520-01 | ML - Milliliter | 72603-520 | 73c187c5-0a97-4c1a-9490-c7f1312f67d0 | 1 | 2025-01-14 |
| 72603-520-02 | ML - Milliliter | 72603-520 | aea62892-c6b4-4f9a-a3c2-8499099f8798 | 1 | 2025-01-14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Lifestar Pharma LLC | f43e4abd-0083-4fe5-9c27-0ba9245e5138 | 2026-07-30 | Warnings, Adverse reactions | 216859 ANDA216859 |
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | NorthStar RxLLC | 3ce681eb-8580-49bf-962a-68a576fddd57 | 2024-09-02 | Warnings, Adverse reactions | 216859 ANDA216859 72603-520-02 72603-520 72603052002 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1234579 | phenylephrine HCl 2.5 % Ophthalmic Solution | PSN | 3ce681eb-8580-49bf-962a-68a576fddd57 | 1 |
| 1234579 | phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution | SCD | 3ce681eb-8580-49bf-962a-68a576fddd57 | 1 |
| 1234579 | phenylephrine hydrochloride 2.5 % Ophthalmic Solution | SY | 3ce681eb-8580-49bf-962a-68a576fddd57 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 72603-520-02 | 72603052002 | 1 BOTTLE, DROPPER in 1 CARTON (72603-520-02) / 15 mL in 1 BOTTLE, DROPPER | 2024-10-01 | No | No | Current |